Company news

Moderna, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Moderna Files for Authorization with Health Canada for its COVID-19 Vaccine in Adolescents

June 6, 2021

Moderna Announces Agreement to Supply the Republic of Botswana with its COVID-19 Vaccine

June 2, 2021

Moderna Announces New Drug Substance Production Agreement with Lonza in the Netherlands

June 1, 2021

Moderna Announces Agreement with Thermo Fisher Scientific for Fill/Finish Manufacturing of Moderna’s COVID-19 Vaccine

May 31, 2021

Moderna Announces TeenCOVE Study of its COVID-19 Vaccine in Adolescents Meets Primary Endpoint and Plans to Submit Data to Regulators in Early June

May 24, 2021

Moderna and Aldevron Announce Expanded Partnership for mRNA Vaccine and Therapeutic Pipeline

May 23, 2021

Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine

May 21, 2021

Moderna to Establish an International Business Services Hub in Warsaw, Poland

May 18, 2021

Moderna Announces New Supply Agreement with Australia for 25 Million Doses of its COVID-19 Vaccine

May 11, 2021

Moderna Announces New Supply Agreement with Switzerland for 7 Million Booster Vaccine Doses in 2022 and Option for Additional 7 Million Doses

May 5, 2021

Moderna Announces Positive Initial Booster Data Against SARS-CoV-2 Variants of Concern

May 4, 2021

Moderna Announces Expansion of its Manufacturing Technology Center in Massachusetts

May 3, 2021

Moderna Announces Supply Agreement with Gavi for up to 500 Million Doses of COVID-19 Vaccine Moderna for COVAX To Help End COVID-19 Pandemic in Lowest Income Countries

May 2, 2021

Moderna Announces Emergency Use Listing Granted by the World Health Organization for its COVID-19 Vaccine

April 29, 2021

Moderna Announces Additional Investments to Increase Global Supply for COVID-19 Vaccine to up to 3 Billion Doses in 2022

April 28, 2021

Moderna Announces Agreement with Sanofi for Fill/Finish Manufacturing of the Moderna COVID-19 Vaccine in the U.S.

April 25, 2021

Moderna Announces New Supply Agreement with Israel for 2022

April 19, 2021

Moderna to Report First Quarter Financial Results on Thursday, May 6, 2021

April 15, 2021

Moderna Announces Clinical Progress from its Industry-Leading mRNA Vaccine Franchise and Continues Investments to Accelerate Pipeline Development

April 13, 2021

Moderna Provides Clinical and Supply Updates on COVID-19 Vaccine Program Ahead of 2nd Annual Vaccines Day

April 12, 2021

Moderna and Catalent Announce Long-Term Strategic Collaboration for Dedicated Vial Filling of Moderna’s COVID-19 Vaccine and Clinical Portfolio

April 5, 2021

Moderna Provides Storage Update & Announces the U.S. FDA Authorizes Up To 15-Doses Per Vial of its COVID-19 Vaccine

March 31, 2021

Moderna to Host Second Annual Virtual Vaccines Day on April 14, 2021

March 30, 2021

Moderna Announces Shipment of 100 Millionth Dose of its COVID-19 Vaccine to the U.S. Government

March 28, 2021

Moderna Announces New Supply Agreement with the Philippines for 7 Million Additional Doses of COVID-19 Vaccine Moderna

March 21, 2021

Moderna Announces First Participants Dosed in Phase 2/3 Study of COVID-19 Vaccine Candidate in Pediatric Population

March 15, 2021

First Participants Dosed in Phase 1 Study Evaluating mRNA-1283, Moderna’s Next Generation COVID-19 Vaccine

March 14, 2021

Moderna Announces First Participants Dosed in Study Evaluating COVID-19 Booster Vaccine Candidates

March 9, 2021

Shannon Thyme Klinger Joins Moderna as Chief Legal Officer and Corporate Secretary

March 7, 2021

Moderna Announces Supply Agreement to Provide 13 Million Doses of COVID-19 Vaccine Moderna to the Philippines

March 5, 2021

Moderna Announces New Drug Application Submitted to Import and Distribute Moderna’s COVID-19 Vaccine Candidate in Japan

March 4, 2021

Moderna Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Updates

February 24, 2021

Moderna Announces Additional Capital Investments to Increase Global Manufacturing Capacity for COVID-19 Vaccine

February 23, 2021

Moderna Provides U.S. COVID-19 Vaccine Supply Update

February 15, 2021

U.S. Government Purchases Additional 100 Million Doses of Moderna’s COVID-19 Vaccine

February 10, 2021

Moderna Announces COVID-19 Vaccine Supply Agreements with the Government of Taiwan for 5 Million Doses and the Government of Colombia for 10 Million Doses

February 8, 2021

Moderna to Report Fourth Quarter and Full Year 2020 Financial Results on Thursday, February 25, 2021

February 3, 2021

Moderna Announces Amendment to Supply Agreement with Switzerland for an Additional 6 Million Doses of COVID-19 Vaccine Moderna

February 2, 2021

Moderna Confirms Discussions with U.S. Government for Additional 100 Million Doses of the Moderna COVID-19 Vaccine

January 26, 2021

Moderna COVID-19 Vaccine Retains Neutralizing Activity Against Emerging Variants First Identified in the U.K. and the Republic of South Africa

January 24, 2021

Moderna Announces First Participant Dosed in Phase 1/2 Study of Moderna COVID-19 Vaccine in Japan Led by Takeda

January 20, 2021

← Newer news releases

Calls

The 5 newest of 25 calls. Every call is listed under its year.

Decks

The 5 newest of 63 decks. Every deck is listed under its year.